This Biotech Fund Sold $8 Million, Yet Remains Bullish on Terns
A biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Short term financial aid is available to those in need. Find out where to access assistance and improve your situation.
27,173 articlesA biotech fund reduced its Terns Pharmaceuticals position by about $8 million last quarter. Despite the sale, the the...
Berkshire Hathaway faces a pivotal July 22 shareholder vote on a major housing bet. This deep dive explains what’s at...
Today’s move in Redwire shares caught many investors off guard. This article explains why redwire stock crashed today...
On July 16, the stock market faced pressure as a major space-tech name announced a $1 billion convertible notes offer...
Markets can overreact to short-term costs even when the long-term AI story is intact. This article outlines one overs...
Analysts warn that the Social Security funding gap could reach a tipping point in the early 2030s. If policy action s...
Alphabet’s latest 13F filing hints at a notable shift in its investment palette. CME Group now sits atop Alphabet’s d...
A popular finance voice defends billionaires' luxury yachts using a ratio-based approach, prompting critics to call o...
One in four workers faces a five-year promotions drought, a trend with broad personal-finance consequences. The study...
A new Fidelity study finds that Americans with a formal retirement plan report higher confidence in their financial f...
A late-night joke becomes a financial brain-teaser: how the trillionaire milestone reframes wealth and what it means ...
Gen X is turning to facelifts as GLP-1 weight-loss drugs reshape faces, pushing middle-aged adults to consider surgic...